Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$117.80−1.29 (-1.08%)
Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –
Incyte operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Incyte's operating income for the twelve months ending Sep 30, 2026 was $626.51M, down 57.7% year over year. For fiscal 2025 it was $1.51B, up 2368.6% from the year before. Over ten years it grew 40.5% a year on average. The highest annual figure on record is $1.51B in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.51B | +2368.6% |
| FY2024 | Dec 31, 2024 | $61.37M | -90.1% |
| FY2023 | Dec 31, 2023 | $620.53M | +7.1% |
| FY2022 | Dec 31, 2022 | $579.44M | -1.1% |
| FY2021 | Dec 31, 2021 | $585.78M | – |
| FY2020 | Dec 31, 2020 | -$263.68M | -165.6% |
| FY2019 | Dec 31, 2019 | $402.01M | +211.1% |
| FY2018 | Dec 31, 2018 | $129.22M | – |
| FY2017 | Dec 31, 2017 | -$243.39M | -267.9% |
| FY2016 | Dec 31, 2016 | $145.00M | +186.3% |
| FY2015 | Dec 31, 2015 | $50.65M | – |
| FY2014 | Dec 31, 2014 | -$4.80M | – |
| FY2013 | Dec 31, 2013 | -$16.10M | -1502.6% |
| FY2012 | Dec 31, 2012 | $1.15M | – |
| FY2011 | Dec 31, 2011 | -$143.18M | -1119.2% |
| FY2010 | Dec 31, 2010 | $14.05M | – |
| FY2009 | Dec 31, 2009 | -$139.77M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$708.36M | -259.7% |
| Q2 FY2026 | Jun 30, 2026 | $697.90M | +31.6% |
| Q1 FY2026 | Mar 31, 2026 | $301.12M | +46.8% |
| Q4 FY2025 | Dec 31, 2025 | $335.86M | +11.4% |
| Q3 FY2025 | Sep 30, 2025 | $443.52M | +203.6% |
| Q2 FY2025 | Jun 30, 2025 | $530.31M | – |
| Q1 FY2025 | Mar 31, 2025 | $205.17M | +123.3% |
| Q4 FY2024 | Dec 31, 2024 | $301.51M | +61.0% |
| Q3 FY2024 | Sep 30, 2024 | $146.09M | -32.0% |
| Q2 FY2024 | Jun 30, 2024 | -$478.13M | -346.7% |
| Q1 FY2024 | Mar 31, 2024 | $91.90M | +271.0% |
| Q4 FY2023 | Dec 31, 2023 | $187.27M | +167.2% |
| Q3 FY2023 | Sep 30, 2023 | $214.71M | +55.2% |
| Q2 FY2023 | Jun 30, 2023 | $193.78M | -23.8% |
| Q1 FY2023 | Mar 31, 2023 | $24.77M | -78.7% |
| Q4 FY2022 | Dec 31, 2022 | $70.09M | -36.7% |
| Q3 FY2022 | Sep 30, 2022 | $138.38M | -41.2% |
| Q2 FY2022 | Jun 30, 2022 | $254.43M | +80.7% |
| Q1 FY2022 | Mar 31, 2022 | $116.54M | +18.0% |
| Q4 FY2021 | Dec 31, 2021 | $110.73M | -32.6% |
| Q3 FY2021 | Sep 30, 2021 | $235.41M | +4320.0% |
| Q2 FY2021 | Jun 30, 2021 | $140.84M | -39.0% |
| Q1 FY2021 | Mar 31, 2021 | $98.80M | – |
| Q4 FY2020 | Dec 31, 2020 | $164.23M | +72.9% |
| Q3 FY2020 | Sep 30, 2020 | $5.33M | -96.0% |
| Q2 FY2020 | Jun 30, 2020 | $230.77M | +134.0% |
| Q1 FY2020 | Mar 31, 2020 | -$664.00M | -996.5% |
| Q4 FY2019 | Dec 31, 2019 | $95.01M | +15.9% |
| Q3 FY2019 | Sep 30, 2019 | $134.32M | +331.6% |
| Q2 FY2019 | Jun 30, 2019 | $98.61M | +18.5% |
| Q1 FY2019 | Mar 31, 2019 | $74.07M | – |
| Q4 FY2018 | Dec 31, 2018 | $81.98M | – |
| Q3 FY2018 | Sep 30, 2018 | $31.12M | +107.2% |
| Q2 FY2018 | Jun 30, 2018 | $83.24M | +1046.7% |
| Q1 FY2018 | Mar 31, 2018 | -$67.11M | – |
| Q4 FY2017 | Dec 31, 2017 | -$132.42M | -414.7% |
| Q3 FY2017 | Sep 30, 2017 | $15.02M | – |
| Q2 FY2017 | Jun 30, 2017 | $7.26M | – |
| Q1 FY2017 | Mar 31, 2017 | -$133.25M | – |
| Q4 FY2016 | Dec 31, 2016 | $42.08M | – |
See a number that looks wrong?